The mean survival time for patients with tumours low for both stromal CXCL8 and CD68+ infiltration was 167 (95% CI: 150–184) months compared to 156 (95% CI: 141–170) months for one high and 122 (95% CI: 104–141) months for both low. The gene discussed is CXCL8; the disease is neoplasm.